DrugCombination product
cyclo(prolylglycyl) clinical trials
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Biomed Industries, Inc. (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cyclo(prolylglycyl) is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19Status unknownPhase 3Biomed Industries, Inc.NCT04540185Written as NA-831
- Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownPhase 1Biomed Industries, Inc.NCT04480333Written as Drug: NA-831 - 0.10 mg/kg
- A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831CompletedPhase 2Biomed Industries, Inc.NCT03538522Written as N-831(Traneurocin) 10 mg QD